10 Mar 2009
A spokesman for the Department of Health said today (March 10) that initial laboratory analysis of samples of all 41 pharmaceutical products (not including the recalled allopurinol) which were supplied to the Hospital Authority (see annex ) by Europharm had indicated no growth of rhizpous so far in the products.
The spokesman said laboratory tests were on going and the results were expected to be available later this week.
Meanwhile, DH hotline 2125 1122, which operates from 9 am to 10 pm, has so far received more than 4,400 public enquiries.